Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Rahway, New Jersey–based Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings…
WuXi STA expands peptide manufacturing capacity to meet global demand
WuXi STA, a prominent global contract research, development and manufacturing organization (CRDMO), has increased its peptide manufacturing output at its Changzhou campus. Located in southern Jiangsu province in China, Changzhou is part of the Yangtze River Delta region, which is among the most economically developed areas in the country. WuXi STA’s expansion includes two additional…
WuXi STA constructing manufacturing facility in Middletown, Delaware
The Contract Research, Development and Manufacturing Organization (CRDMO) WuXi STA has begun construction on a site in Middletown, Delaware. The company expects it to be operational in 2025. This 190-acre pharmaceutical manufacturing campus will be the company’s second U.S. site and the first on the East Coast. The site will be based in the Middletown…